about
The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with InflammationTransforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer ProgressionIncreased survival after irradiation followed by regeneration of bone marrow stromal cells with a novel thiol-based radioprotector.Doxycycline Inhibits IL-17-Stimulated MMP-9 Expression by Downregulating ERK1/2 Activation: Implications in Myogenic DifferentiationInflammatory cytokines prime adipose tissue mesenchymal stem cells to enhance malignancy of MCF-7 breast cancer cells via transforming growth factor-β1.Mesenchymal stem cells of different origin: Comparative evaluation of proliferative capacity, telomere length and pluripotency marker expression.Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.Characteristics of human adipose mesenchymal stem cells isolated from healthy and cancer affected people and their interactions with human breast cancer cell line MCF-7 in vitro.Interleukin 17 inhibits myogenic and promotes osteogenic differentiation of C2C12 myoblasts by activating ERK1,2.The inhibition of periodontal ligament stem cells osteogenic differentiation by IL-17 is mediated via MAPKs.Lipopolysaccharide can modify differentiation and immunomodulatory potential of periodontal ligament stem cells via ERK1,2 signaling.Mesenchymal stromal cell engagement in cancer cell epithelial to mesenchymal transition.Mesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton's jellyAdipoinductive effect of extracellular matrix involves cytoskeleton changes and SIRT1 activity in adipose tissue stem/stromal cellsIL-33 guides osteogenesis and increases proliferation and pluripotency marker expression in dental stem cells
P50
Q28073691-8EFE3649-CE21-4E09-B7C7-59C1C65F92A7Q28083526-464355B6-8717-4B16-B727-9D2CE9D1CE86Q37620975-F74E0380-52ED-472C-85B5-C20CBC7095CEQ38723327-149EE6C0-3930-453F-9A3B-5B4F8E87F0AAQ38799898-DE642564-B03D-4CE7-AC12-70B498D34F30Q38832230-7E408F57-3C47-4462-9701-613DCD871EE3Q38937047-6B468C04-4520-4E59-B574-0684F41FF516Q39071952-FDB22445-4FD2-43A1-A7CA-793933003506Q39404968-4C3E99AB-B601-41E2-B70F-10BB15F23B4CQ40156794-99C387DF-CA43-47BF-A71C-45555B2C78B5Q47335104-578F5D37-D1C7-4909-A6E5-0151CCA04710Q48162218-73B75022-477B-45B8-A99C-0359467DB99CQ86913938-71CE1BB5-98F9-4F2C-B285-6265D163612AQ91352116-2A022EBB-8F5B-4877-8CCC-927A17C974C1Q93087699-F9982AE3-524C-4F8E-85AC-1428DC3A7EFE
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Drenka Trivanović
@en
Drenka Trivanović
@nl
type
label
Drenka Trivanović
@en
Drenka Trivanović
@nl
prefLabel
Drenka Trivanović
@en
Drenka Trivanović
@nl
P31
P496
0000-0001-7041-3917